OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry
Ghislaine Scélo, Carlos A. Torres‐Duque, Jorge Máspero, et al.
Annals of Allergy Asthma & Immunology (2023) Vol. 132, Iss. 1, pp. 42-53
Open Access | Times Cited: 22

Showing 22 citing articles:

Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma
Michael E. Wechsler, Ghislaine Scélo, Désirée Larenas‐Linnemann, et al.
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 209, Iss. 3, pp. 262-272
Open Access | Times Cited: 24

Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma Across Multiple Clinically Relevant Subgroups in the NAVIGATOR Study
Tara F. Carr, Wendy C. Moore, Monica Kraft, et al.
Advances in Therapy (2024) Vol. 41, Iss. 7, pp. 2978-2990
Open Access | Times Cited: 7

Remission in asthma
Marek Lommatzsch
Current Opinion in Pulmonary Medicine (2024) Vol. 30, Iss. 3, pp. 325-329
Open Access | Times Cited: 6

The impact of biologic therapy on work capacity and workforce attachment in patients with severe asthma
Kjell Erik Julius Håkansson, Rikke Ibsen, Niels Steen Krogh, et al.
Journal of Asthma (2025), pp. 1-11
Closed Access

Asthma Exacerbation Comorbidity Index (AECI): Predicting In-Hospital Adverse Outcomes
Chongyang Zhao, Gang Wang, Li Zhang, et al.
Respiratory Medicine (2025) Vol. 240, pp. 108024-108024
Closed Access

Comorbidities and multimorbidity in asthma
Diego J. Maselli, J. Sherratt, Sandra Adams
Current Opinion in Pulmonary Medicine (2025)
Closed Access

Real-World Biologic Use Patterns in Severe Asthma, 2015–2021: The CLEAR Study
Trung N. Tran, Stephanie Chen, Benjamin Emmanuel, et al.
Pragmatic and Observational Research (2025) Vol. Volume 16, pp. 51-66
Open Access

ASSOCIATION BETWEEN THE -444C POLYMORPHISM IN THE LTC4S GENE AND COMORBIDITY RISK IN PATIENTS WITH BRONCHIAL ASTHMA
Maryna Kochuieva, Валентина Григорьевна Псарева, Nataliia Cherednychenko, et al.
Eastern Ukrainian Medical Journal (2025) Vol. 13, Iss. 1, pp. 111-121
Open Access

Identifying Super-Responders: a Review of the Road to Asthma Remission
Samuel Mailhot-Larouche, C.A. Celis-Preciado, Liam G. Heaney, et al.
Annals of Allergy Asthma & Immunology (2024)
Open Access | Times Cited: 4

Real-World Effectiveness of Mepolizumab in Severe Asthma: Results from the Multi-country, Self-controlled Nucala Effectiveness Study (NEST)
Riyad Al‐Lehebi, Mona Al‐Ahmad, Venkata Nagarjuna Maturu, et al.
Advances in Therapy (2024) Vol. 41, Iss. 11, pp. 4008-4031
Open Access | Times Cited: 3

Analyzing comorbidities and their influence on severe asthma
Arjun Mohan, Brinda Desai, Njira Lugogo
Annals of Allergy Asthma & Immunology (2024) Vol. 132, Iss. 3, pp. 259-260
Open Access | Times Cited: 2

Difficult-To-Treat and Severe Asthma: Can Real-World Studies On Effectiveness of Biological Treatments Change the Lives of Patients?
Corrado Pelaia, Antonio Giacalone, Gianluca Ippolito, et al.
Pragmatic and Observational Research (2024) Vol. Volume 15, pp. 45-51
Open Access | Times Cited: 2

Big Data Research on Severe Asthma
Sang Hyuk Kim, Youlim Kim
Tuberculosis & respiratory diseases (2024) Vol. 87, Iss. 3, pp. 213-220
Open Access | Times Cited: 2

Understanding the impact of breathing pattern disorders in difficult-to-treat asthma
J.J. Hudson-Colby, Adam Lewis, Judit Varkonyi-Sepp, et al.
Expert Review of Respiratory Medicine (2024)
Closed Access | Times Cited: 1

Efficacité des biothérapies de l’asthme sévère sur les comorbidités allergiques
Charlotte Thibaut de Ménonville, L. Barakat, F. Laborier, et al.
Revue des Maladies Respiratoires (2024) Vol. 41, Iss. 9, pp. 669-679
Closed Access | Times Cited: 1

Necrotizing pneumonia in children: a case series
Silvia Carraro, Michele Piazza, Laura Badina, et al.
(2024) Vol. 02, Iss. 03, pp. 120-120
Open Access

Tezepelumab: a promising therapy for severe uncontrolled asthma
Argyri Klironomou, Georgia Papaiakovou, Agamemnon Bakakos, et al.
(2024) Vol. 2, Iss. 6, pp. 485-501
Closed Access

Baseline Characteristics of Dupilumab-Treated Patients with Asthma in the Real World: The RAPID Global Registry
Njira Lugogo, Xavier Soler, Yasuhiro Gon, et al.
Advances in Therapy (2024) Vol. 42, Iss. 2, pp. 849-862
Open Access

Assessing the Underdiagnosis of Allergic Rhinitis Correlations with Asthma and Quality of Life in Saudi Paediatric Populations: A Cross-sectional Study
Kawthar Mohammed Aleid, Kawther Ibrahim Alhawsawi, Amani Ahmed Mutaen, et al.
(2024) Vol. 1, Iss. 1, pp. 268-274
Closed Access

Biologics as well as inhaled anti-asthmatic therapy achieve clinical remission: Evidence from the Severe Asthma Network in Italy (SANI)
Giorgio Walter Canonica, Francesco Blasi, Pierluigi Paggiaro, et al.
World Allergy Organization Journal (2024) Vol. 18, Iss. 1, pp. 101016-101016
Open Access

Page 1

Scroll to top